{"entity":{"id":"nct03178032","kind":"trial","name":"Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas","aka":[],"tldr":"A phase 1 trial of DNX-2401 run by Clinica Universidad de Navarra, Universidad de Navarra, completed.","summary":"Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas is a phase 1 interventional study registered as NCT03178032 by Clinica Universidad de Navarra, Universidad de Navarra, with 12 participants enrolled, started 2017-05-26. Conditions recorded: Brainstem Glioma and Neoadjuvant Therapy. Interventions recorded: DNX-2401.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT03178032","url":"https://clinicaltrials.gov/study/NCT03178032"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["brain-tumours"],"sections":[],"technologies":[],"targets":[],"drugs":["dnx-2401"],"companies":["dnatrix"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03178032","phase":"1","setting":"Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.","sponsor":"Clinica Universidad de Navarra, Universidad de Navarra","enrolled":12,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03178032/","neighbours":{"cancer":[{"id":"brain-tumours","kind":"cancer","name":"Brain and spinal cord tumours (all types)","route":"/cancers/brain-tumours/"}],"drug":[{"id":"dnx-2401","kind":"drug","name":"DNX-2401","route":"/drugs/dnx-2401/"}],"company":[{"id":"dnatrix","kind":"company","name":"DNAtrix","route":"/companies/dnatrix/"}]}}